<SEC-DOCUMENT>0000059478-20-000190.txt : 20201215
<SEC-HEADER>0000059478-20-000190.hdr.sgml : 20201215
<ACCEPTANCE-DATETIME>20201215072719
ACCESSION NUMBER:		0000059478-20-000190
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20201215
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201215
DATE AS OF CHANGE:		20201215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ELI LILLY & Co
		CENTRAL INDEX KEY:			0000059478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				350470950
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-06351
		FILM NUMBER:		201388209

	BUSINESS ADDRESS:	
		STREET 1:		LILLY CORPORATE CTR
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285
		BUSINESS PHONE:		3172762000

	MAIL ADDRESS:	
		STREET 1:		LILLY CORPORATE CENTER
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LILLY ELI & CO
		DATE OF NAME CHANGE:	19941024
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lly-20201215.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:9373579f-5e01-4e99-8d5e-f164addf6f4d,g:4650b838-7efb-4978-9abe-b7d21f0d08d0,d:3a13a01599b34d108a5e6673152f8d32--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:lly="http://www.lilly.com/20201215" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lly-20201215</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl80L2ZyYWc6YTllNDFjZTI4NzhhNDJkYWE3ZjExZmI3N2NjYzM1NDEvdGFibGU6ZmY0OWViOTIzN2Q4NDkxYWFiZjVjOTMzMGVlNjI4MjcvdGFibGVyYW5nZTpmZjQ5ZWI5MjM3ZDg0OTFhYWJmNWM5MzMwZWU2MjgyN18yLTEtMS0xLTA_a17b1e19-f35b-4679-a244-cdf594a46707">0000059478</ix:nonNumeric><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl80L2ZyYWc6YTllNDFjZTI4NzhhNDJkYWE3ZjExZmI3N2NjYzM1NDEvdGFibGU6ZmY0OWViOTIzN2Q4NDkxYWFiZjVjOTMzMGVlNjI4MjcvdGFibGVyYW5nZTpmZjQ5ZWI5MjM3ZDg0OTFhYWJmNWM5MzMwZWU2MjgyN181LTEtMS0xLTA_0a9d22f0-7a3c-4a2d-aeef-40d8df7e5d26">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lly-20201215.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A1.000NotesDueJune22022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A718NotesDueJune12025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A1.625NotesDueJune22026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A2.125NotesDueJune32030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A625Notesdue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A6.77NotesDueJanuary12036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000059478</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A1.700Notesdue2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-15</xbrli:startDate><xbrli:endDate>2020-12-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3a13a01599b34d108a5e6673152f8d32_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:1.2pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Washington, D.C. 20549</span></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.146%"><tr><td style="width:1.0%"></td><td style="width:26.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.360%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:13.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMw_c1d474cd-f755-4c9d-ab33-c3a12fa51908">8-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.146%"><tr><td style="width:1.0%"></td><td style="width:26.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.360%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:2.2pt;margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:13.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xMDk5NTExNjI5MjQw_e238a7bb-0841-4598-af8c-b5b6c061c9de">December 15, 2020</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.146%"><tr><td style="width:1.0%"></td><td style="width:26.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.360%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMx_30546896-da46-4c45-983b-1fe48d266eb0">ELI LILLY AND COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (Exact Name of Registrant as Specified in its Charter)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.146%"><tr><td style="width:1.0%"></td><td style="width:26.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.360%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.978%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.885%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6ZTA2YmMyNDc4OWM2NGI5NzlmMmMzNjE1MjMwMmM3NjYvdGFibGVyYW5nZTplMDZiYzI0Nzg5YzY0Yjk3OWYyYzM2MTUyMzAyYzc2Nl8wLTAtMS0xLTA_bd3369c9-fcc4-448c-8686-c737698fdc35">Indiana</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6ZTA2YmMyNDc4OWM2NGI5NzlmMmMzNjE1MjMwMmM3NjYvdGFibGVyYW5nZTplMDZiYzI0Nzg5YzY0Yjk3OWYyYzM2MTUyMzAyYzc2Nl8wLTItMS0xLTA_5f40b673-eac2-430b-bfe4-341ad380f493">001-06351</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6ZTA2YmMyNDc4OWM2NGI5NzlmMmMzNjE1MjMwMmM3NjYvdGFibGVyYW5nZTplMDZiYzI0Nzg5YzY0Yjk3OWYyYzM2MTUyMzAyYzc2Nl8wLTQtMS0xLTA_95860254-088e-418e-93f1-c6efac036607">35-0470950</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">        <ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDI3_627f1af7-f01e-4eb8-a427-1199d83568bf">Lilly Corporate Center</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    <ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMy_84ac102c-11c8-4bff-bd83-72ea06fb2c04">Indianapolis</ix:nonNumeric>, <ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDI4_40977120-3435-453c-a72d-5f35f992bf0b">Indiana</ix:nonNumeric> <ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDI5_9973c862-aba0-4557-a858-95e4bda91984">46285</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices, and Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMz_6de7f4d4-9712-46bc-8f03-c3163325e6be">317</ix:nonNumeric>) <ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDM0_a3d10999-b396-4f37-92d3-f37e21b59a8d">276-2000</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> (Former Name or Former Address, if Changed Since Last Report.)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2.):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6MzM4ZTQxMjYzNWU1NDRiZmJlNjUwM2JlNjdhNWNlNWIvdGFibGVyYW5nZTozMzhlNDEyNjM1ZTU0NGJmYmU2NTAzYmU2N2E1Y2U1Yl8wLTAtMS0xLTA_08146b22-26ea-4c66-8f39-e2b4a2175d76">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6YzJmNjY4NzFmNGQyNDkzODljZTI5Mzk3MWM5MTU3NTYvdGFibGVyYW5nZTpjMmY2Njg3MWY0ZDI0OTM4OWNlMjkzOTcxYzkxNTc1Nl8wLTAtMS0xLTA_684de583-3aa3-44fb-b9de-f6950afdfbc5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6NmVlZWU3YjhlMGQzNDZkNDgxNmI0NTViYzQwMjI0MmEvdGFibGVyYW5nZTo2ZWVlZTdiOGUwZDM0NmQ0ODE2YjQ1NWJjNDAyMjQyYV8wLTAtMS0xLTA_61b8aaee-66a6-41f5-8393-fe0e7885ae28">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:2.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6YmE2ZWNlYTQxODY3NDY1MGEwYjQwZGIwYzBlYjkyOGYvdGFibGVyYW5nZTpiYTZlY2VhNDE4Njc0NjUwYTBiNDBkYjBjMGViOTI4Zl8wLTAtMS0xLTA_679ee1af-730a-45c3-8a81-b3934fabcf4a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18xLTAtMS0xLTA_2c729e62-4d63-4d2d-a180-59f8937f138c">Common Stock (no par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18xLTItMS0xLTA_81bff4df-95ad-4329-8000-9cabfc945e18">LLY</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18xLTQtMS0xLTA_6b142dbe-b861-405e-b6db-ef0b93391a88">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18yLTAtMS0xLTA_cbc91c4f-f7b3-43a5-aef7-9f3315f8203a">1.000% Notes due 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18yLTItMS0xLTA_3aca0f91-8346-4404-aa91-4ffe97f79206">LLY22</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18yLTQtMS0xLTA_23d56059-e9ec-4a52-933f-ab62792609e8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18zLTAtMS0xLTA_6c987025-2d54-4156-9281-fade28a53593">7 1/8% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18zLTItMS0xLTA_29bd2f92-14c3-4e62-8d7f-3d6ff9d3e8b0">LLY25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18zLTQtMS0xLTA_f4a52e4b-cdfd-4f50-b954-c673bc1057bc">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY180LTAtMS0xLTA_ca8db353-5949-4e69-bc06-f4b3bbd43d2c">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY180LTItMS0xLTA_b66b2a96-695e-407f-a750-5b1ed75a4f1e">LLY26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY180LTQtMS0xLTA_87d52880-72ec-4dfb-ab5e-edc1dd13f057">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY181LTAtMS0xLTA_faababd7-edb5-4340-85b5-86d08a8ab5e4">2.125% Notes due 2030</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY181LTItMS0xLTA_78f2a262-24f9-43db-9920-be665d9187f9">LLY30</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY181LTQtMS0xLTA_c6b2db53-0852-40d9-b325-fccd65e7b703">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY182LTAtMS0xLTA_90224226-bd81-4d1c-9327-c0db3497f98b">0.625% Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY182LTItMS0xLTA_3348979d-5931-42f2-96c8-8ecfdbe78820">LLY31</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY182LTQtMS0xLTA_f03dba10-85eb-4811-bf48-5c1a8f87645e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY183LTAtMS0xLTA_ca024941-b75d-4007-a377-25578afb7593">6.77% Notes due 2036</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY183LTItMS0xLTA_a4c3836f-c5f8-4944-abe5-02da82111cc3">LLY36</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY183LTQtMS0xLTA_e2581745-bbf1-4504-9f9d-a600aac180d7">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY184LTAtMS0xLTA_2e1ee105-cebe-424b-b18d-a752014178b2">1.700% Notes due 2049</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY184LTItMS0xLTA_0b4c487b-e739-4a82-901a-e9d099d06335">LLY49A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY184LTQtMS0xLTA_4c0ea87c-d419-4243-974f-274b393a67b6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDM1_0c9554c5-608a-4565-97d2-5af0df0dc26d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i3a13a01599b34d108a5e6673152f8d32_7"></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2.02.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 15, 2020, Eli Lilly and Company (the &#8220;Company&#8221;) issued a press release updating its financial guidance for</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, and announcing its financial guidance for 2021. In addition, on the same day, the Company held a teleconference for analysts and media to discuss this guidance. The teleconference was webcast on the Company&#8217;s web site. The press release is attached to this Form 8-K as Exhibit 99.1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses non-GAAP financial measures that differ from financial statements reported in conformity with U.S.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generally accepted accounting principles (&#8220;GAAP&#8221;), and the press release attached as Exhibit 99.1 includes a</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">description of certain non-GAAP items that may affect the Company&#8217;s financial expectations for 2020 and 2021. The</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s non-GAAP financial measures adjust reported results to exclude amortization of intangibles and items that are</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">typically highly variable, difficult to predict, and/or of a size that could have a substantial impact on the Company&#8217;s reported</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations for a period. The Company believes that these non-GAAP financial measures provide useful information to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investors in evaluating the Company&#8217;s performance. They can assist in making meaningful period-over-period comparisons and in identifying operating trends that would otherwise be masked or distorted by the items subject to the adjustments. Management uses these non-GAAP financial measures internally to evaluate the performance of the Company&#8217;s business, including to allocate resources and to evaluate results relative to incentive compensation targets. Investors should consider these non-GAAP financial measures in addition to, not as a substitute for or superior to, measures of financial performance prepared in accordance with GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the liabilities of that Section and shall not be deemed incorporated by reference into any registration statement or other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such filing.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01.            Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)           Exhibits</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:15.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lly-2021financialguida.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lly-2021financialguida.htm">Press release dated December 15, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:49.707%"><tr><td style="width:1.0%"></td><td style="width:15.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.666%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">ELI LILLY AND COMPANY</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(Registrant)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">/s/ Donald A. Zakrowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Donald A. Zakrowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Vice President, Finance, and Chief Accounting Officer</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Date:  December 15, 2020</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lly-2021financialguida.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i3a4da71cc9f4437087fd9634ff9cf18d_1"></div><div style="min-height:129.6pt;width:100%"><div style="padding-left:360pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:65px;margin-bottom:5pt;vertical-align:text-bottom;width:119px"></div><div style="padding-left:360pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eli Lilly and Company</font></div><div style="padding-left:360pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Lilly Corporate Center</font></div><div style="padding-left:360pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indianapolis, Indiana 46285</font></div><div style="padding-left:360pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">U.S.A.</font></div><div style="padding-left:360pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">+1.317.276.2000</font></div><div style="padding-left:360pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">www.lilly.com</font></div><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">December 15, 2020</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">For Release&#58;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:117%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Immediately</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">Refer to&#58;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark Taylor&#59; mark.taylor&#64;lilly.com&#59; (317) 276-5795 (Media)</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Kevin Hern&#59; hern_kevin_r&#64;lilly.com&#59; (317) 277-1838 (Investors) </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">Lilly Announces 2021 Financial Guidance, Updates 2020 Guidance</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:13.8pt">Lilly expects to deliver strong financial and operational performance in 2021, highlighted by volume-based revenue growth, operating margin expansion, pipeline advancements and solid cash flow.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:13.8pt">2021 revenue is expected to be between $26.5 billion and $28.0 billion, driven by volume growth from key growth products, including Trulicity, Taltz, Verzenio, Jardiance, Olumiant, Cyramza, Emgality, Tyvyt, and Retevmo, as well as an estimated $1 billion to $2 billion of revenue from COVID-19 therapies.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:13.8pt">Operating margin is expected to be approximately 30 percent on a reported basis and approximately 32 percent on a non-GAAP basis in 2021.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:13.8pt">Earnings per share (EPS) for 2021 are expected to be in the range of $7.25 to $7.90 on a reported basis and $7.75 to $8.40 on a non-GAAP basis. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%;padding-left:13.8pt">Continued pipeline progress in 2021 will include a number of Phase 3 data readouts for important investigational medicines and new indications, the initiation of several new Phase 3 clinical trials, and the possibility of multiple regulatory submissions and approvals. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:13.8pt">For 2020, the company now expects revenue to be between $24.2 billion and $24.7 billion, and earnings per share to be in the range of $6.28 to $6.48 on a reported basis and $7.45 to $7.65 on a non-GAAP basis.</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">INDIANAPOLIS, IN - Eli Lilly and Company (NYSE&#58; LLY) today announced its 2021 financial guidance, highlighted by volume-based revenue growth, increased investment in research and development, operating margin expansion and strong earnings performance. The company also revised certain elements of its 2020 financial guidance and reviewed potential key events for the upcoming year, including important data readouts for several investigational medicines in its clinical pipeline and the possibility of multiple regulatory submissions and approvals. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The company&#8217;s 2020 and 2021 financial guidance are being provided on both a reported and a non-GAAP basis. Reported guidance is presented in accordance with U.S. generally accepted accounting </font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">principles (GAAP). Non-GAAP measures reflect adjustments for the items described in the associated reconciliation tables. The non-GAAP measures are presented to provide additional insights into the underlying trends in the company&#8217;s business.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Josh Smiley, Lilly&#8217;s chief financial officer, outlined the company&#8217;s near-term growth prospects and provided 2021 financial guidance. &#8220;We&#8217;re pleased with our performance despite the unprecedented challenges facing the world in 2020. We expect 2021 to be another exciting year for Lilly, characterized by robust volume-driven revenue growth for our key medicines, while we continue to invest in and progress our pipeline, expand operating margins and deliver impressive EPS and cash flow growth. Reflecting this growth, we have announced a 15 percent increase in our dividend for 2021. One year after we outlined our high-level outlook through 2025, we are increasingly confident in our ability to deliver top-tier revenue growth and operating margin percent expansion into the mid-to-high 30s during this timeframe.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Commenting on the company&#8217;s cash flow expectations, Smiley added, &#8220;We expect to deliver strong cash flow in 2021, which we will continue to deploy thoughtfully across our capital allocation priorities. We remain focused on funding our existing marketed products, new launches, lifecycle opportunities and replenishing our pipeline. We will continue to leverage bolt-on acquisitions and licensing opportunities to augment our future growth prospects with external innovation. Finally, we plan to return cash to shareholders through an increased dividend and our ongoing share repurchase program, while maintaining strong investment grade ratings.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">&#8220;Lilly is in the midst of an exciting period of prolonged growth for the company, driven by an expanding portfolio of new medicines focused on diabetes, oncology, immunology, and neuroscience,&#8221; said David A. Ricks, Lilly&#8217;s chairman and chief executive officer. &#8220;We enter 2021 emboldened by the lessons we have learned during the COVID-19 pandemic, the agility and persistence we have displayed, and the knowledge that we are supported by one of the fastest growing portfolios in the industry. With more exciting data readouts and innovation prospects on the way, we have a remarkable opportunity to make life better for many more patients who can benefit from Lilly medicines.&#8221;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%;text-decoration:underline">2020 Financial Guidance</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The company has updated certain elements of its 2020 financial guidance. On a reported basis, earnings per share for 2020 are now expected to be in the range of $6.28 to $6.48. On a non-GAAP basis, earnings per share for 2020 are now expected to be in the range of $7.45 to $7.65. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The following reconciliation table provides further details on non-GAAP measures&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:59.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:139%">2020</font></div><div style="margin-bottom:2pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:139%">Expectations</font></div></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">% Change from 2019</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">Earnings per share (reported)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">$6.28 to $6.48</font></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">27% to 31%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Acquired IPR&#38;D</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">.66</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Amortization of intangible assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">.36</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Asset impairment, restructuring and other special charges</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">.15</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">Earnings per share (non-GAAP)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">$7.45 to $7.65</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">23% to 27%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:162%">Numbers may not add due to rounding</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:5.2pt;font-weight:400;line-height:142%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:142%"> Reported earnings per share percent change from 2019 is calculated based on change from 2019 earnings per share from continuing operations.</font></div><div style="margin-top:2pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:5.2pt;font-weight:400;line-height:162%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:162%"> Includes costs related to business development transactions with a pre-clinical stage company, Sitryx Therapeutics, AbCellera Biologics, Evox Therapeutics, Junshi Biosciences, Innovent, Disarm Therapeutics and Fochon Pharmaceuticals. Excludes costs related to the business development transaction with Precision BioSciences.</font></div><div style="margin-top:2pt"><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Revenue for 2020 is now expected to be in the range of $24.2 billion to $24.7 billion, reflecting expectations of increased bamlanivimab sales due to an additional purchase agreement with the U.S. government. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Gross margin as a percent of revenue is still expected to be approximately 78 percent on a reported basis and is now expected to be approximately 79 percent on a non-GAAP basis, reflecting expectations of increased bamlanivimab sales.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Marketing, selling and administrative expenses are still expected to be in the range of $6.0 billion to $6.1 billion. Research and development expenses are still expected to be in the range of $5.8 billion to $5.9 billion.</font></div><div><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Operating margin, defined as operating income as a percent of revenue, is still expected to be approximately 25 percent on a reported basis, and is now expected to be approximately 30 percent on a non-GAAP basis. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Other income (expense) is now expected to be income in the range of $600 million to $700 million, reflecting additional projected gains on investments in equity securities. The market valuations for these securities could fluctuate significantly throughout the remainder of the year, with current valuations placing other income (expense) above the revised 2020 guidance range.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The 2020 effective tax rate is still expected to be approximately 14 percent on both a reported basis and a non-GAAP basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The following table summarizes the company&#8217;s 2020 financial guidance&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:44.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.210%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">2020 Guidance</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Prior</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Updated</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Revenue</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$23.7 to $24.2 billion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$24.2 to $24.7 billion</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Gross Margin % of Revenue (reported)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 78%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Unchanged</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Gross Margin % of Revenue (non-GAAP)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 80%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 79%</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Marketing, Selling &#38; Administrative</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$6.0 to $6.1 billion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Unchanged</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Research &#38; Development</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$5.8 to $5.9 billion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Unchanged</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Other Income&#47;(Expense)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$450 to $600 million</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$600 to $700 million</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Tax Rate</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 14%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Unchanged</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Earnings per share (reported)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$6.20 to $6.40</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$6.28 to $6.48</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Earnings per share (non-GAAP)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$7.20 to $7.40</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$7.45 to $7.65</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Operating Margin (reported)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">25%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Unchanged</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Operating Margin (non-GAAP)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">29%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 30%</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Non-GAAP guidance reflects adjustments presented in the earnings per share table above.</font></td></tr></table></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%;text-decoration:underline">Change in Non-GAAP Measures Beginning in 2021</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Beginning in 2021, the company will exclude the gains and losses on investments in equity securities from its non-GAAP measures for other income (expense) and earnings per share. Reflecting this change in the company&#8217;s updated 2020 financial guidance as detailed above would result in the exclusion of approximately $900 million of expected other income, thereby lowering the company&#8217;s 2020 expectations for other income (expense) on a non-GAAP basis to be expense in the range of $200 million to $300 million, and lowering the company&#8217;s earnings per share expectations on a non-GAAP basis for 2020 by approximately $0.75 per share to be in the range of $6.70 to $6.90.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%;text-decoration:underline">2021 Financial Guidance</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The company today issued its 2021 financial guidance. Earnings per share for 2021 are expected to be in the range of $7.25 to $7.90 on a reported basis and $7.75 to $8.40 on a non-GAAP basis. As noted, 2021 financial results will exclude gains and losses on investments in equity securities from non-GAAP measures. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The following reconciliation table provides further details on 2021 non-GAAP measures&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.147%"><tr><td style="width:1.0%"></td><td style="width:66.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.249%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%">2021</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%">Expectations</font></div></td><td colspan="6" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">Earnings per share (reported)</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">$7.25 to $7.90</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Amortization of intangible assets</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">.50</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">Earnings per share (non-GAAP)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%">$7.75 to $8.40</font></td><td colspan="6" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:120%">Numbers may not add due to rounding</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:120%"> Excludes costs related to the pending acquisition of Prevail Therapeutics.</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The company anticipates 2021 revenue between $26.5 billion and $28.0 billion, including an estimated $1 billion to $2 billion of revenue from COVID-19 therapies. Revenue growth is expected to be driven by volume from key growth products including Trulicity</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, Taltz</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, Verzenio</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, Jardiance</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, Olumiant</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, Cyramza</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, Emgality</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, Tyvyt</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, and Retevmo</font><font style="color:#000000;font-family:'Garamond',serif;font-size:7.8pt;font-weight:400;line-height:150%;position:relative;top:-4.2pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">, as well as by COVID-19 therapies. Revenue growth is expected to be partially offset by lower revenue for products that have recently lost patent exclusivity. The company expects mid-single digit net price declines globally in 2021. In the U.S., the company expects low-to-mid-single digit net price declines, driven primarily by increased rebates to maintain broad commercial access and segment mix, partially offset by the benefit from the implementation of a limited distribution program in the company&#8217;s 340B program. Outside the U.S., the company expects net price declines in China, Japan and Europe. </font></div><div><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Gross margin as a percent of revenue for 2021 is expected to be approximately 77 percent on a reported basis, and approximately 79 percent on a non-GAAP basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Marketing, selling and administrative expenses for 2021 are expected to be in the range of $6.2 billion to $6.4 billion. Research and development expenses for 2021 are expected to be in the range of $6.5 billion to $6.7 billion, including approximately $300 million to $400 million of continued investment in COVID-19 therapies.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Operating margin for 2021 is expected to be approximately 30 percent on a reported basis and approximately 32 percent on a non-GAAP basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Other income (expense) for 2021 is expected to be expense in the range of $200 million to $300 million on both a reported basis and on a non-GAAP basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The 2021 effective tax rate is expected to be approximately 15 percent on both a reported basis and on a non-GAAP basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">The following table summarizes the company&#8217;s 2021 financial guidance.  </font></div><div><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:43.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.579%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">2021 Guidance</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Revenue</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$26.5 to $28.0 billion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Gross Margin % of Revenue (reported)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 77%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Gross Margin % of Revenue (non-GAAP)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 79%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Marketing, Selling &#38; Administrative</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$6.2 to $6.4 billion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Research &#38; Development</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$6.5 to $6.7 billion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Other Income&#47;(Expense)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$(300) to ($200) million</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Tax Rate</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 15%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Earnings per share (reported)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$7.25 to $7.90</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Earnings per share (non-GAAP)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">$7.75 to $8.40</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:19pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Operating Margin (reported)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 30%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Operating Margin (non-GAAP)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Approx. 32%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">Non-GAAP guidance reflects adjustments presented in the earnings per share table above.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%;text-decoration:underline">Webcast of Conference Call</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">As previously announced, investors and the general public can access a live webcast of the 2021 financial guidance conference call through a link on Lilly&#8217;s website at www.lilly.com. The conference call will begin at 8&#58;30 a.m. Eastern time (ET) today and will be available for replay via the website.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%;text-decoration:underline">About</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%;text-decoration:underline">&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:150%;text-decoration:underline">Eli Lilly and Company</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:150%">Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. F-LLY</font></div><div><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">This press release contains management&#8217;s current intentions and expectations for the future, all of which are forward- looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words &#8220;estimate&#8221;, &#8220;project&#8221;, &#8220;intend&#8221;, &#8220;expect&#8221;, &#8220;believe&#8221;, &#8220;target&#8221;, &#8220;anticipate&#8221; and similar expressions are intended to identify forward-looking statements. Actual results may differ materially due to various factors. There are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company&#8217;s business. There can be no guarantees that pipeline products will receive the necessary clinical and manufacturing regulatory approvals, that they will prove to be commercially successful, that the company will identify or complete any acquisitions or licensing opportunities, or that the company&#8217;s deployment of capital will favorably impact its financial position. The company&#8217;s results may also be affected by such factors as the timing of anticipated regulatory approvals and launches of new products&#59; market uptake of recently launched products&#59; competitive developments affecting current products and the company&#8217;s pipeline&#59; the expiration of intellectual property protection for certain of the company&#8217;s products&#59; the company&#8217;s ability to protect and enforce patents and other intellectual property&#59; the impact of actions of governmental and private payers affecting the pricing of, reimbursement for, and access to pharmaceuticals&#59; regulatory compliance problems or government investigations&#59; regulatory actions regarding currently marketed products&#59; safety or efficacy concerns associated with the company&#8217;s products&#59; issues with product supply stemming from manufacturing difficulties or disruptions&#59; regulatory changes or other developments&#59; changes in patent law or regulations related to data-package exclusivity&#59; litigation involving past, current or future products&#59; unauthorized disclosure, misappropriation, or compromise of trade secrets or other confidential data stored in the company&#8217;s information systems, networks and facilities, or those of third parties with which the company shares its data&#59; changes in tax law and regulations, including the impact of U.S. tax reform legislation enacted in December 2017 and related guidance&#59; changes in inflation, interest rates, and foreign currency exchange rates&#59; asset impairments and restructuring charges&#59; changes in accounting standards promulgated by the Financial Accounting Standards Board and the Securities and Exchange Commission (SEC)&#59; acquisitions and business development transactions and related integration costs&#59; the company&#8217;s ability to effectuate its potential dividend program and share repurchase activity&#59; information technology system inadequacies or operating failures&#59; the impact of the evolving COVID-19 pandemic, and the global response thereto&#59; reliance on third-party relationships and outsourcing arrangements&#59; and global macroeconomic conditions. In addition, the company may not be able to reliably predict the impact of specified items in its 2021 guidance beyond the next 12 months, and the variability of factors discussed in these forward looking statements could have a significant and unpredictable impact on the company&#8217;s future GAAP results. For additional information about the factors that could cause actual results to differ materially from forward-looking statements, please see the company&#8217;s latest Form 10-K and subsequent Forms 10-Q and 8-K filed with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. Except as is required by law, the company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this release.</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;#&#160;&#160;&#160;&#160;#&#160;&#160;&#160;&#160;#</font></div><div style="padding-right:-90pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">Cyramza</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%"> (ramucirumab, Lilly)</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">Emgality</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%"> (galcanezumab-gnlm, Lilly)</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">Jardiance</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">(empagliflozin, Boehringer Ingelheim)</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">Olumiant</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%"> (baricitinib, Lilly)</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:120%">Retevmo</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:120%"> (selpercatinib, Lilly)</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">Taltz</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">(ixekizumab, Lilly)</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">Trulicity</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">(dulaglutide, Lilly)</font></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:120%">Tyvyt</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:120%"> (sintilimab injection, Lilly)</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:129.6pt;width:100%"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%">Verzenio</font><font style="color:#000000;font-family:'Garamond',serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:139%"> (abemaciclib, Lilly)</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lly-20201215.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:9373579f-5e01-4e99-8d5e-f164addf6f4d,g:4650b838-7efb-4978-9abe-b7d21f0d08d0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lly="http://www.lilly.com/20201215" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lilly.com/20201215">
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lly-20201215_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lly-20201215_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lly-20201215_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lly-20201215_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.lilly.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lly_A1.700Notesdue2049Member" abstract="true" name="A1.700Notesdue2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lly_A2.125NotesDueJune32030Member" abstract="true" name="A2.125NotesDueJune32030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lly_A718NotesDueJune12025Member" abstract="true" name="A718NotesDueJune12025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lly_A1.625NotesDueJune22026Member" abstract="true" name="A1.625NotesDueJune22026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lly_A6.77NotesDueJanuary12036Member" abstract="true" name="A6.77NotesDueJanuary12036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lly_A1.000NotesDueJune22022Member" abstract="true" name="A1.000NotesDueJune22022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lly_A625Notesdue2031Member" abstract="true" name="A625Notesdue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>lly-20201215_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:9373579f-5e01-4e99-8d5e-f164addf6f4d,g:4650b838-7efb-4978-9abe-b7d21f0d08d0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lilly.com/role/CoverPage" xlink:type="simple" xlink:href="lly-20201215.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.lilly.com/role/CoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>lly-20201215_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:9373579f-5e01-4e99-8d5e-f164addf6f4d,g:4650b838-7efb-4978-9abe-b7d21f0d08d0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lilly.com/role/CoverPage" xlink:type="simple" xlink:href="lly-20201215.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.lilly.com/role/CoverPage" xlink:type="extended" id="i42a6a48ab7c648c082b15063bafa1e30_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e3c86108-db6a-4796-ab17-17b5469404e6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_DocumentType_e3c86108-db6a-4796-ab17-17b5469404e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_38b210b4-557a-4010-ad14-166449c1a8c9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_DocumentPeriodEndDate_38b210b4-557a-4010-ad14-166449c1a8c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f5745c91-3be4-41a0-9dca-a5640e6aa02b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f5745c91-3be4-41a0-9dca-a5640e6aa02b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c6f654d9-6dc9-4769-bb4c-ab0cd0b877a0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityFileNumber_c6f654d9-6dc9-4769-bb4c-ab0cd0b877a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_32548504-8bce-4f5f-b740-56ed265e1e61" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityTaxIdentificationNumber_32548504-8bce-4f5f-b740-56ed265e1e61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d1230163-0c1a-46ea-b238-1997220004fa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressAddressLine1_d1230163-0c1a-46ea-b238-1997220004fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6aacfa88-5d8c-4a43-9dbb-1435d855be8f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressCityOrTown_6aacfa88-5d8c-4a43-9dbb-1435d855be8f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_624fb590-bb20-4f14-9c21-52bcaa9d64a4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressStateOrProvince_624fb590-bb20-4f14-9c21-52bcaa9d64a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1754889e-af1e-46dc-a6b6-7e995f91a2a6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressPostalZipCode_1754889e-af1e-46dc-a6b6-7e995f91a2a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6e0a8f42-d106-46df-ba45-330ca24e60f2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_CityAreaCode_6e0a8f42-d106-46df-ba45-330ca24e60f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_585877e5-40bd-49b6-8182-8860e7e8b839" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_LocalPhoneNumber_585877e5-40bd-49b6-8182-8860e7e8b839" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d29d984d-1b99-4c27-97f8-ee79e3bccd64" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_WrittenCommunications_d29d984d-1b99-4c27-97f8-ee79e3bccd64" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_86ef8694-1055-462d-8b09-da491092c9a3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_SolicitingMaterial_86ef8694-1055-462d-8b09-da491092c9a3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_1143b1d0-78ea-4774-9e67-0f3a6c134e87" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_PreCommencementTenderOffer_1143b1d0-78ea-4774-9e67-0f3a6c134e87" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_13b7e2c6-2b56-4ff8-b472-2887ef14bbf0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_13b7e2c6-2b56-4ff8-b472-2887ef14bbf0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5727d5fc-618d-478e-a29e-c3ed6a5b5299" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityEmergingGrowthCompany_5727d5fc-618d-478e-a29e-c3ed6a5b5299" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a26de187-cfcb-43f2-9225-3c951161f6c2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_Security12bTitle_a26de187-cfcb-43f2-9225-3c951161f6c2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_57eadbcc-a8b6-44bf-a261-1c6c5d402c95" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_TradingSymbol_57eadbcc-a8b6-44bf-a261-1c6c5d402c95" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ad906b03-c810-4f0c-ba0f-ab43c2605c44" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_SecurityExchangeName_ad906b03-c810-4f0c-ba0f-ab43c2605c44" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_91136df4-43ad-4cd9-9f70-a4e0bdccd229" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityRegistrantName_91136df4-43ad-4cd9-9f70-a4e0bdccd229" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_53177590-1418-4bee-979b-f96e62b9142f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityCentralIndexKey_53177590-1418-4bee-979b-f96e62b9142f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_83780b49-e811-4ed7-a01e-04c0fc460363" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_AmendmentFlag_83780b49-e811-4ed7-a01e-04c0fc460363" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_d66e9c7d-f19a-4e22-98c0-094e380678b6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_DocumentInformationTable_d66e9c7d-f19a-4e22-98c0-094e380678b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_933680db-9313-4b12-ac7d-ac229a39bad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_d66e9c7d-f19a-4e22-98c0-094e380678b6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_933680db-9313-4b12-ac7d-ac229a39bad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_933680db-9313-4b12-ac7d-ac229a39bad5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_933680db-9313-4b12-ac7d-ac229a39bad5" xlink:to="loc_us-gaap_ClassOfStockDomain_933680db-9313-4b12-ac7d-ac229a39bad5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_933680db-9313-4b12-ac7d-ac229a39bad5" xlink:to="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_e0631bcf-303b-436b-890e-80221a821f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_us-gaap_CommonClassAMember_e0631bcf-303b-436b-890e-80221a821f83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.000NotesDueJune22022Member_7adcfe12-ca19-4052-b5db-6f2956719b30" xlink:href="lly-20201215.xsd#lly_A1.000NotesDueJune22022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A1.000NotesDueJune22022Member_7adcfe12-ca19-4052-b5db-6f2956719b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A718NotesDueJune12025Member_0587be28-55cd-4777-9503-0d39a4269ecc" xlink:href="lly-20201215.xsd#lly_A718NotesDueJune12025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A718NotesDueJune12025Member_0587be28-55cd-4777-9503-0d39a4269ecc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.625NotesDueJune22026Member_95a8d6c4-c71e-4eb0-9bf4-d311738232a8" xlink:href="lly-20201215.xsd#lly_A1.625NotesDueJune22026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A1.625NotesDueJune22026Member_95a8d6c4-c71e-4eb0-9bf4-d311738232a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A2.125NotesDueJune32030Member_3f189371-bddf-4b06-bd70-d7ae9a018758" xlink:href="lly-20201215.xsd#lly_A2.125NotesDueJune32030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A2.125NotesDueJune32030Member_3f189371-bddf-4b06-bd70-d7ae9a018758" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A625Notesdue2031Member_9b31104d-98d3-4675-a40e-7fc3256d3b46" xlink:href="lly-20201215.xsd#lly_A625Notesdue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A625Notesdue2031Member_9b31104d-98d3-4675-a40e-7fc3256d3b46" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A6.77NotesDueJanuary12036Member_bc807c3b-e287-4fc9-b0e7-400501d45b91" xlink:href="lly-20201215.xsd#lly_A6.77NotesDueJanuary12036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A6.77NotesDueJanuary12036Member_bc807c3b-e287-4fc9-b0e7-400501d45b91" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.700Notesdue2049Member_be3d131b-32b1-4dec-aa13-634bd6625901" xlink:href="lly-20201215.xsd#lly_A1.700Notesdue2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A1.700Notesdue2049Member_be3d131b-32b1-4dec-aa13-634bd6625901" xlink:type="arc" order="7"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>lly-20201215_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:9373579f-5e01-4e99-8d5e-f164addf6f4d,g:4650b838-7efb-4978-9abe-b7d21f0d08d0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d17fea0a-714f-4195-8910-f03ccf103f18_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_12349024-11a1-4c2b-8ad3-5ca452f121a6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_lly_A1.625NotesDueJune22026Member_8e707c5a-a7b2-476d-aa74-51d6fcfa4aea_terseLabel_en-US" xlink:label="lab_lly_A1.625NotesDueJune22026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes due 2026</link:label>
    <link:label id="lab_lly_A1.625NotesDueJune22026Member_label_en-US" xlink:label="lab_lly_A1.625NotesDueJune22026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due June 2, 2026 [Member]</link:label>
    <link:label id="lab_lly_A1.625NotesDueJune22026Member_documentation_en-US" xlink:label="lab_lly_A1.625NotesDueJune22026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due June 2, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.625NotesDueJune22026Member" xlink:href="lly-20201215.xsd#lly_A1.625NotesDueJune22026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lly_A1.625NotesDueJune22026Member" xlink:to="lab_lly_A1.625NotesDueJune22026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ed314574-0914-47a7-bbb4-636b275e35a7_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_52c49a5c-0b83-45ea-aca3-dc201118d19e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_lly_A1.700Notesdue2049Member_c985c1d9-0e9d-49b9-baad-1e537ccb8fd2_terseLabel_en-US" xlink:label="lab_lly_A1.700Notesdue2049Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.700% Notes due 2049</link:label>
    <link:label id="lab_lly_A1.700Notesdue2049Member_label_en-US" xlink:label="lab_lly_A1.700Notesdue2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.700% Notes due 2049 [Member]</link:label>
    <link:label id="lab_lly_A1.700Notesdue2049Member_documentation_en-US" xlink:label="lab_lly_A1.700Notesdue2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.700% Notes due 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.700Notesdue2049Member" xlink:href="lly-20201215.xsd#lly_A1.700Notesdue2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lly_A1.700Notesdue2049Member" xlink:to="lab_lly_A1.700Notesdue2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_94c92dea-c43d-4816-a242-5cebb4613d70_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_385704a4-b99c-465e-9502-e3e9c45ad804_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_150bbad9-19b2-40be-8f6e-ca2b25ab5f68_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ceba9a90-f2ec-4cc5-b9a8-c9c28c6e22ad_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d92d75d8-4d0a-4479-9ddf-088aba765eb8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b5509e58-5480-47ee-92fb-3f704a1d4ecc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_aedbfa70-540e-46ac-8284-dbc81e4b65ed_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4cd84e4b-d54f-4546-9376-8564f95db4a6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_lly_A1.000NotesDueJune22022Member_2f53a37c-6f51-4889-b2ea-2d715575eda7_terseLabel_en-US" xlink:label="lab_lly_A1.000NotesDueJune22022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2022</link:label>
    <link:label id="lab_lly_A1.000NotesDueJune22022Member_label_en-US" xlink:label="lab_lly_A1.000NotesDueJune22022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes Due June 2, 2022 [Member]</link:label>
    <link:label id="lab_lly_A1.000NotesDueJune22022Member_documentation_en-US" xlink:label="lab_lly_A1.000NotesDueJune22022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes Due June 2, 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.000NotesDueJune22022Member" xlink:href="lly-20201215.xsd#lly_A1.000NotesDueJune22022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lly_A1.000NotesDueJune22022Member" xlink:to="lab_lly_A1.000NotesDueJune22022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_3b765f04-c8c3-4805-8601-a0654ff64bd8_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_cf7d0e94-3dfc-4876-bf99-5a065769d0ac_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_16136ec5-a646-420f-94be-fd4ce083f56d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_lly_A6.77NotesDueJanuary12036Member_5c1360eb-a7eb-4bad-9f7f-32e7686a4b1e_terseLabel_en-US" xlink:label="lab_lly_A6.77NotesDueJanuary12036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.77% Notes due 2036</link:label>
    <link:label id="lab_lly_A6.77NotesDueJanuary12036Member_label_en-US" xlink:label="lab_lly_A6.77NotesDueJanuary12036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.77%&#160;Notes Due January&#160;1, 2036 [Member]</link:label>
    <link:label id="lab_lly_A6.77NotesDueJanuary12036Member_documentation_en-US" xlink:label="lab_lly_A6.77NotesDueJanuary12036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.77%&#160;Notes Due January&#160;1, 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A6.77NotesDueJanuary12036Member" xlink:href="lly-20201215.xsd#lly_A6.77NotesDueJanuary12036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lly_A6.77NotesDueJanuary12036Member" xlink:to="lab_lly_A6.77NotesDueJanuary12036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d114a944-dcde-4133-858c-145819eea2aa_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a39baa00-8890-46a4-8f79-c98b49ecc83e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_lly_A718NotesDueJune12025Member_7a3ee472-ffcd-45d7-9186-0fdae1d9f188_terseLabel_en-US" xlink:label="lab_lly_A718NotesDueJune12025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7 1/8% Notes due 2025</link:label>
    <link:label id="lab_lly_A718NotesDueJune12025Member_label_en-US" xlink:label="lab_lly_A718NotesDueJune12025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7 1/8% Notes Due June&#160;1, 2025 [Member]</link:label>
    <link:label id="lab_lly_A718NotesDueJune12025Member_documentation_en-US" xlink:label="lab_lly_A718NotesDueJune12025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7 1/8% Notes Due June&#160;1, 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A718NotesDueJune12025Member" xlink:href="lly-20201215.xsd#lly_A718NotesDueJune12025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lly_A718NotesDueJune12025Member" xlink:to="lab_lly_A718NotesDueJune12025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lly_A2.125NotesDueJune32030Member_dad71a8d-5a53-4075-b3e2-dc33bf39a641_terseLabel_en-US" xlink:label="lab_lly_A2.125NotesDueJune32030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Notes due 2030</link:label>
    <link:label id="lab_lly_A2.125NotesDueJune32030Member_label_en-US" xlink:label="lab_lly_A2.125NotesDueJune32030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Notes Due June 3, 2030 [Member]</link:label>
    <link:label id="lab_lly_A2.125NotesDueJune32030Member_documentation_en-US" xlink:label="lab_lly_A2.125NotesDueJune32030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Notes Due June 3, 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A2.125NotesDueJune32030Member" xlink:href="lly-20201215.xsd#lly_A2.125NotesDueJune32030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lly_A2.125NotesDueJune32030Member" xlink:to="lab_lly_A2.125NotesDueJune32030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_1334ee7f-7807-4a45-a4b6-49cc9bb3228d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f3817640-9cfa-4c07-91b9-69cea2f780ff_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f77d6428-c49a-45cc-a003-d83da3779134_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_9d2dda2a-1ea5-486a-a804-01605193bf5d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_84ba004b-8953-450c-a761-792a372b57cc_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_7b94ada3-7be1-4e67-81cb-5982547f2bd0_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_75467705-bf5d-4eb4-86ff-b4099d117b7f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_5236a700-0c78-4dff-b652-cb158a3864ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock (no par value)</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c5122b2c-1231-4c37-ac68-544c47ebf6fa_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3141ffbb-6e23-4519-8a84-5fadc6ed8eb0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_lly_A625Notesdue2031Member_c689c130-853f-4724-91d9-8ffd08414339_terseLabel_en-US" xlink:label="lab_lly_A625Notesdue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% Notes due 2031</link:label>
    <link:label id="lab_lly_A625Notesdue2031Member_label_en-US" xlink:label="lab_lly_A625Notesdue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">.625% Notes due 2031 [Member]</link:label>
    <link:label id="lab_lly_A625Notesdue2031Member_documentation_en-US" xlink:label="lab_lly_A625Notesdue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">.625% Notes due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A625Notesdue2031Member" xlink:href="lly-20201215.xsd#lly_A625Notesdue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lly_A625Notesdue2031Member" xlink:to="lab_lly_A625Notesdue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_452ae4ac-b60d-4b70-8723-787658107af6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>lly-20201215_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:9373579f-5e01-4e99-8d5e-f164addf6f4d,g:4650b838-7efb-4978-9abe-b7d21f0d08d0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lilly.com/role/CoverPage" xlink:type="simple" xlink:href="lly-20201215.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.lilly.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f5fb64f1-98d5-4987-b363-6564b31f88d3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_d66e9c7d-f19a-4e22-98c0-094e380678b6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f5fb64f1-98d5-4987-b363-6564b31f88d3" xlink:to="loc_dei_DocumentInformationTable_d66e9c7d-f19a-4e22-98c0-094e380678b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_933680db-9313-4b12-ac7d-ac229a39bad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_d66e9c7d-f19a-4e22-98c0-094e380678b6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_933680db-9313-4b12-ac7d-ac229a39bad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_933680db-9313-4b12-ac7d-ac229a39bad5" xlink:to="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_e0631bcf-303b-436b-890e-80221a821f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_us-gaap_CommonClassAMember_e0631bcf-303b-436b-890e-80221a821f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.000NotesDueJune22022Member_7adcfe12-ca19-4052-b5db-6f2956719b30" xlink:href="lly-20201215.xsd#lly_A1.000NotesDueJune22022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A1.000NotesDueJune22022Member_7adcfe12-ca19-4052-b5db-6f2956719b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A718NotesDueJune12025Member_0587be28-55cd-4777-9503-0d39a4269ecc" xlink:href="lly-20201215.xsd#lly_A718NotesDueJune12025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A718NotesDueJune12025Member_0587be28-55cd-4777-9503-0d39a4269ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.625NotesDueJune22026Member_95a8d6c4-c71e-4eb0-9bf4-d311738232a8" xlink:href="lly-20201215.xsd#lly_A1.625NotesDueJune22026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A1.625NotesDueJune22026Member_95a8d6c4-c71e-4eb0-9bf4-d311738232a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A2.125NotesDueJune32030Member_3f189371-bddf-4b06-bd70-d7ae9a018758" xlink:href="lly-20201215.xsd#lly_A2.125NotesDueJune32030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A2.125NotesDueJune32030Member_3f189371-bddf-4b06-bd70-d7ae9a018758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A625Notesdue2031Member_9b31104d-98d3-4675-a40e-7fc3256d3b46" xlink:href="lly-20201215.xsd#lly_A625Notesdue2031Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A625Notesdue2031Member_9b31104d-98d3-4675-a40e-7fc3256d3b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A6.77NotesDueJanuary12036Member_bc807c3b-e287-4fc9-b0e7-400501d45b91" xlink:href="lly-20201215.xsd#lly_A6.77NotesDueJanuary12036Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A6.77NotesDueJanuary12036Member_bc807c3b-e287-4fc9-b0e7-400501d45b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lly_A1.700Notesdue2049Member_be3d131b-32b1-4dec-aa13-634bd6625901" xlink:href="lly-20201215.xsd#lly_A1.700Notesdue2049Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9d50d600-016a-4deb-877c-0d14985ae8a5" xlink:to="loc_lly_A1.700Notesdue2049Member_be3d131b-32b1-4dec-aa13-634bd6625901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_d66e9c7d-f19a-4e22-98c0-094e380678b6" xlink:to="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e3c86108-db6a-4796-ab17-17b5469404e6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_DocumentType_e3c86108-db6a-4796-ab17-17b5469404e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_38b210b4-557a-4010-ad14-166449c1a8c9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_DocumentPeriodEndDate_38b210b4-557a-4010-ad14-166449c1a8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f5745c91-3be4-41a0-9dca-a5640e6aa02b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f5745c91-3be4-41a0-9dca-a5640e6aa02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c6f654d9-6dc9-4769-bb4c-ab0cd0b877a0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityFileNumber_c6f654d9-6dc9-4769-bb4c-ab0cd0b877a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_32548504-8bce-4f5f-b740-56ed265e1e61" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityTaxIdentificationNumber_32548504-8bce-4f5f-b740-56ed265e1e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d1230163-0c1a-46ea-b238-1997220004fa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressAddressLine1_d1230163-0c1a-46ea-b238-1997220004fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6aacfa88-5d8c-4a43-9dbb-1435d855be8f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressCityOrTown_6aacfa88-5d8c-4a43-9dbb-1435d855be8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_624fb590-bb20-4f14-9c21-52bcaa9d64a4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressStateOrProvince_624fb590-bb20-4f14-9c21-52bcaa9d64a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1754889e-af1e-46dc-a6b6-7e995f91a2a6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityAddressPostalZipCode_1754889e-af1e-46dc-a6b6-7e995f91a2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6e0a8f42-d106-46df-ba45-330ca24e60f2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_CityAreaCode_6e0a8f42-d106-46df-ba45-330ca24e60f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_585877e5-40bd-49b6-8182-8860e7e8b839" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_LocalPhoneNumber_585877e5-40bd-49b6-8182-8860e7e8b839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d29d984d-1b99-4c27-97f8-ee79e3bccd64" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_WrittenCommunications_d29d984d-1b99-4c27-97f8-ee79e3bccd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_86ef8694-1055-462d-8b09-da491092c9a3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_SolicitingMaterial_86ef8694-1055-462d-8b09-da491092c9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_1143b1d0-78ea-4774-9e67-0f3a6c134e87" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_PreCommencementTenderOffer_1143b1d0-78ea-4774-9e67-0f3a6c134e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_13b7e2c6-2b56-4ff8-b472-2887ef14bbf0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_13b7e2c6-2b56-4ff8-b472-2887ef14bbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5727d5fc-618d-478e-a29e-c3ed6a5b5299" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityEmergingGrowthCompany_5727d5fc-618d-478e-a29e-c3ed6a5b5299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a26de187-cfcb-43f2-9225-3c951161f6c2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_Security12bTitle_a26de187-cfcb-43f2-9225-3c951161f6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_57eadbcc-a8b6-44bf-a261-1c6c5d402c95" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_TradingSymbol_57eadbcc-a8b6-44bf-a261-1c6c5d402c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ad906b03-c810-4f0c-ba0f-ab43c2605c44" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_SecurityExchangeName_ad906b03-c810-4f0c-ba0f-ab43c2605c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_91136df4-43ad-4cd9-9f70-a4e0bdccd229" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityRegistrantName_91136df4-43ad-4cd9-9f70-a4e0bdccd229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_53177590-1418-4bee-979b-f96e62b9142f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_EntityCentralIndexKey_53177590-1418-4bee-979b-f96e62b9142f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_83780b49-e811-4ed7-a01e-04c0fc460363" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_265c50e0-72a8-4dc6-acb2-995fd14225b5" xlink:to="loc_dei_AmendmentFlag_83780b49-e811-4ed7-a01e-04c0fc460363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
MB5!.1PT*&@H    -24A$4@   X0   'K" 8   "7<U.=    "7!(67,  "XC
M   N(P%XI3]V   *3VE#0U!0:&]T;W-H;W @24-#('!R;V9I;&4  'C:G5-G
M5%/I%CWWWO1"2XB E$MO4A4((%)"BX 4D28J(0D02H@AH=D54<$1144$&\B@
MB ..CH",%5$L#(H*V ?D(:*.@Z.(BLK[X7NC:]:\]^;-_K77/N>L\YVSSP?
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M_R)B8N/^Y<^K<$   .%T?M'^+"^S&H [!H!M_J(E[@1H7@N@=?>+9K(/0+4
MH.G:5_-P^'X\/$6AD+G9V>7DY-A*Q$);8<I7??YGPE_ 5_UL^7X\_/?UX+[B
M)($R78%'!/C@PLST3*4<SY()A&+<YH]'_+<+__P=TR+$26*Y6"H4XU$2<8Y$
MFHSS,J4BB4*2*<4ETO]DXM\L^P,^WS4 L&H^ 7N1+:A=8P/V2R<06'3 XO<
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M0\<PP.@8!S/$;# NQL-"L3@L"9-CR[$BK RKQAJP5JP#NXGU8\^Q=P02@47
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ME:1%9[U<4<( GD/_&Z;Z$U1( " 0MB#\#4+0^W,G!%8EES0/(7'>62]S[@(
M B$(A    F&] ?!#^,]>PY<TE_2ELU[.N3L "(0@$ ( "(3EA\ TA+^/>MV4
MSSJM)$T[Z^6,.P80" $"(0" 0'A\"/PH::CF1P%?&PS'G?5R02T&"(0 @1
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M\*%$Q2C.)7<%)=3K-(3!'J4!  "!$,"OG>7A3@BTXB.!$"74[Y&*G4032@,
M@'9CZ@F@GT8!/X0@:+FC/.ZLES/N&@ZLZZP7=(PIHT <F#(*2Q@A1-M#X' G
M!'IQ(8E B$/J.^L%"XOPGZE\C9)FW#H  ($0.*Y3W-L)@5X[QKU-MS_LK)=S
M[BCVK/>IVGN^8!8"X%^2LH>;,H6RN9"/CT(YM1D 0" $7M\93N1S)/ YGR01
M"+%O&+Q3N]8+KB1]D31[Z>S.SGJ923K;=/N7(1@2" $ K<):!,3<$1Y%%@(?
M.NVLEPON-%YX!FY:]),7DCX?.GJ^Z?;O9'OFP+2S7EY2LP'_6$,(2Q@A1&P=
MX%3%Z-E0\8^(7.C'6BC@X;-P*?LC7F4&P6D)'T@^&P^$.34; $ @!'[M^":2
M1B$(]EKTTP>;;C\-4]Z W6?B)CP3!,'7__LLXUD' ! (@9U.[T#%N7RC%A?#
M)TEC:@/",Y&H6"^81OY35RJ.7RDUP'76RWS3[5O_W0  E(HUA/#8X1VJF K7
MHT0D2>]>VC@#A,%(Y"I&!*\K+$>S"WLX@Q"(!VL(80DCA/#2V>VI& T;J5V[
M)>[C0HP2MOWY2!7_3J)S2>=5?OP(LPZL6E#3 0 $0K2QHSO0CTUB\+C1IMN?
M,DI(&(ST)ZY"$)RW_%9GU'8 0!7>4@0PVLD=A2W@[PB#>_E$$;3S.8D\#%Y+
M.JDQ# X,E\7?U'@ 0!48(83%#B[K U]O.TJ84Q2M>E9B/6,P5[%IS+SF_]_W
MALMD0:T' ! ($6O'-I$T4;%C*$'P,-LRO*0H"(/.S4,8S!OX_QX8+9,54\(!
M %5AQS)8"(*?Q$8Q9<A5[#B:4Q11/S>QGC&8J^(=1%\HUU32O=&RF7762S:.
M B+"+J.PA!%"$ 3CD:A8;SFC* B#SF0J1@6S!J_AH^'R^4KM!P!4A4UE4'>'
M=J3B*_P%8; 2%Q0!8="9F:33AL.@9'OSJ@5/  "@*DP919U!D,UBZC'NK)<S
MBH$P:%RNXCB)F8'R365WNNBJLUZ^XRD XL*445C"E%%4W=$:2+J2E%(:M?DD
MIHW&\OPD*HZ5B.WYR=3\%-%=EJ>+SGD2  !58LHHJNK(]G;.$20,UBL-01R$
M0:L!Y]10&)1LC[[^Q=,  *@2(X2HHA-[H6+3&#3GDUAW1!BT9]I9+R^-E?5(
M=M<SYYWUDN<8 $ @A)M.[$1L%M-X!U+%=#P0!JW5RR8.FM_')\/E-N>)   0
M".&A SL0ZP2;"'TK2?\)?\Y( F'0JDRVU@L^;+LLES7310$ !$*8[[PR/;1:
MBQ#\_@X=ZXR#YPF#SNKOF>$Z:_F8EI71$54  ($0D#;=_E#2C9@>6G;G.=N&
M/XLC*B ,OL*LLUZ.#9?Y0-+ </D1!@$ !$*8[$3U0A <4!I'R4, _!K"WX(B
M(0Q&]+,\G(5Y8?SZOO!T   (A+#6<9V(36,.M=H)@(O.>KFB2!!A&,QE=_.8
MW7(?R/9'+68(   (A##5>>J)4<%#.L;; #@G *(E8?#429"Q/CKXF2<$ $ @
MA)5.ZT2,"NXK"R'P+Z: HF5A, MA,'=0]@/9_KB5B_6#   "(8QT6&_%J.!+
MYBJVAF<:* B#/EQ9;U/821@ 0"!$TQW6H=A!]"EY"(%?Z;B!,&A[)]%'RG_D
MH.RG/"D @#J]H0CPH+/*N8)/A\"_.!<,A$&W83"1="^I9_@R%YWU\I2G!8C?
MO__^2R' #$8(L>TLI2I&!5-*X[NYBNF@C 2B##&%00_'2CPT,1X&)3:3 0 T
M@!%";*=178DIHE*Q'NJ+BM$/0B#*>L9N)(T(@XV5?T_2-^.7N>JLE^]X6H!V
M8(00EC!"V.Y.:A*"X*CE19&K& W\S-E?( P^^YR,G4Z;OG%PC:P=!  T@A'"
M]G92>RIV$4U;7 Q9"($S:@0(@R^&P5./'TS")EFWQB^3T4&@91@AA"6,$+:S
MDSH(':2DA3\_%Z.!( RV)0PF8G00   "(7[J($UD_QRN*JQ4K V\9FT@:GK.
M1I$\-V>./YY<R/Z'KQ6S%   !$+4U4F-:6.+?2TD?:'#A1J?LY'B^.B2R=>!
M\P_OPT ^CM!A=!  T"C6$+:C@YHHKBWO]PV"T\YZN: &H.8P>!/!3_$>!A/9
M/W-08NT@T%JL(80EC!#&WT%-U:[S!6=B?2":>=:&A$$S+AR$08G100"  8P0
MQA\&[]2.S6-F*D8$5]QY\*RU-PR&J:)W#BZ5T4&@Q1@AA"6,$,;;01VJ&*V(
M/0P2!$$8) QN[T4B/Z.TC X"  B$J*Q3-%(<4]>>LY!TSM10-/RL]2()@[/P
M/.7.?\>-?$P57;#1%0" 0 C"X.%!D,UB8.%92Q3'>9ZSSGHYCN!^#"4-G5PN
MHX,   (A*ND07:K83"%&*Q4C&'/N-(R$P1AV[HTE#/;DYT/8C ]:   "(:KH
M$,5ZQF"N8M?02^XR#(EAY]XHPN#._4B<M&>,#@( "(0@#.[;854<ZYH0W_,V
M) R:N1^7D@9.+O<S&V ! *SAV G"H$59"((+[C",/6]7DB:$03/W8R ?1TQ(
MQ;3W$SYP 9 X=@($0A &GY*KV##FFKL+@\_;2/XW;(HI#":2OLG/ICYGK($&
M0""$14P9]=TYC2D,SE6,"JZXNR ,$@;WX&F'USEA$ ! ( 2=T\?EDL9TEF#X
M>4LE71$&3=V32_E9-YA+.N=) @!8]98B( PV:"[I'6$0QL.@]X/G8PN#0_DZ
M7F?*S < @&6L(?37.;V/X*?D8E00]I^W1/[/&HPM#/9"&^@EH&>=]?*$IPG
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M#SU42A$ (! VR^+ZP2R&K>_1FD[@C<-+=[VC:%BO>27_FW00!N-H!RY5'*&
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MK]V^GNE$Q>8QJ?.?,M-A.XB^%#9ZAG[C9VKL]WLS"F$]C>#G#"7U-MT^1_*
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M7H5GL[W/;B)_QTM8"H.6PTPNZ9WEYW?3[5_)_V'SN8ICP:[W+>NP^="%H=_
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M_;3MUD:XO(3!7+;6#5[*U_KRN8K1L;K"X%#VIFY/.^OE):TE"(38-E2>-AP
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MW<ATT4?/18MDO:#4XJEH82?889//^2$S2(Q,<RWM6>+=<U#_@MDD<8;!@_H
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MHF-&,-SMR\S5PME,X>BL&]J*RC\RO/M?__?_T.9X"(1OWKS9?4 (AX];[ 3
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MC#M(( 0   !PN!MG85"2S@F#!$(     1]AT^S>2ALXN>]Q9+V?</0(A
M@,/#X$32R-EEGQ,&F\$NHP#@M0%GEU$ P*]A<"1_9PW..NOEN,Q_(1F'0 @
M!$( 0-O"8"KIONUAD$#X.DP9!0   .((@W?.+CN3=,[=(Q "    .#P,)O)W
MUF"FXGB)G#M(( 0   !P.(]G#9X1!@F$     (X0CI?P%@9/.^OEBKM'( 0
M  !P>!B<R-_Q$F,.GK>%748!P&L#SBZC -#F,#B4=.LP#,[J^#\BX^R/$4(
M  # 5QA,Y>^LP6L.GK>)$4( \-J ,T(( &T,@XF*LP9[CBZ[DK,&GT/&V1\C
MA    ( ?=\["8%9W& 2!$    (B.PQU%,TFGW#D"(0   (#CPN!(OG84S55L
M(I-S]VQC#2$ >&W 64,( &T)@P,54T4].6GR> DRSOX8(00   #LAL&>?!XO
MD7'W"(0     #@^#20B#B:/+GG*\!($0    P/&NY&L3F5EGO;SDMA$( 0
M !QAT^U/Y&L3F4S2.7?.'S:5 0"O#3B;R@! K&%P(%^;R*Q4;"*36[D@,@Z!
M$  (A   CV$PD?1-?M8-YI).K6TB0\;9'U-& 0   #ONY&L3&784)1 "
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M'TJ:.+G<7&PBTRH<.P$ 7AMPCIT   ]AL"?I7GZFBI[$L&Z0C+,_1@@!  "
MZGA:-\@F,@1"     &78=/N7D@9.+G?662^ON6OMPY11 /#:@#-E%  LA\%4
MQ511#S))IS&=-TC&V1\CA    $"Y83"1=.OD<G-)8PZ?)Q "    *,>%I)Z3
M:V7=8,LQ910 O#;@3!D% '/"$1->1@=GG?5R'.-](./LCQ%"    H)PPF*C8
M5=2#3!*'SX- "    )3$RQ$3N5@W" (A    4(Y-MS^2-'1RN:P;Q'>L(00
MKPTX:P@!P$H8[*DX8B)Q<+G1KAO<1<;9'R.$    P'&\3!7-Q+I!$ @!  "
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M8,HH    8F+Y(/I<["P* B$   !0OG#41,_P)<Z8*@H"(0   % -\P?1<XM
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M$+<CB+T]_K%?-I,A$() "  @$ * _X#8T\\CB(\%Q'>=]7)%( 2!$ ! ( 2
I^ /B<"<@9IWU\O2I_SW];UCR_P< I-(1?\/]?<L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>lly-20201215_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:lly="http://www.lilly.com/20201215"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lly-20201215.xsd" xlink:type="simple"/>
    <context id="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A1.000NotesDueJune22022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A718NotesDueJune12025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A1.625NotesDueJune22026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A2.125NotesDueJune32030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A625Notesdue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A6.77NotesDueJanuary12036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000059478</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lly:A1.700Notesdue2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl80L2ZyYWc6YTllNDFjZTI4NzhhNDJkYWE3ZjExZmI3N2NjYzM1NDEvdGFibGU6ZmY0OWViOTIzN2Q4NDkxYWFiZjVjOTMzMGVlNjI4MjcvdGFibGVyYW5nZTpmZjQ5ZWI5MjM3ZDg0OTFhYWJmNWM5MzMwZWU2MjgyN18yLTEtMS0xLTA_a17b1e19-f35b-4679-a244-cdf594a46707">0000059478</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl80L2ZyYWc6YTllNDFjZTI4NzhhNDJkYWE3ZjExZmI3N2NjYzM1NDEvdGFibGU6ZmY0OWViOTIzN2Q4NDkxYWFiZjVjOTMzMGVlNjI4MjcvdGFibGVyYW5nZTpmZjQ5ZWI5MjM3ZDg0OTFhYWJmNWM5MzMwZWU2MjgyN181LTEtMS0xLTA_0a9d22f0-7a3c-4a2d-aeef-40d8df7e5d26">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMw_c1d474cd-f755-4c9d-ab33-c3a12fa51908">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xMDk5NTExNjI5MjQw_e238a7bb-0841-4598-af8c-b5b6c061c9de">2020-12-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMx_30546896-da46-4c45-983b-1fe48d266eb0">ELI LILLY AND COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6ZTA2YmMyNDc4OWM2NGI5NzlmMmMzNjE1MjMwMmM3NjYvdGFibGVyYW5nZTplMDZiYzI0Nzg5YzY0Yjk3OWYyYzM2MTUyMzAyYzc2Nl8wLTAtMS0xLTA_bd3369c9-fcc4-448c-8686-c737698fdc35">IN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6ZTA2YmMyNDc4OWM2NGI5NzlmMmMzNjE1MjMwMmM3NjYvdGFibGVyYW5nZTplMDZiYzI0Nzg5YzY0Yjk3OWYyYzM2MTUyMzAyYzc2Nl8wLTItMS0xLTA_5f40b673-eac2-430b-bfe4-341ad380f493">001-06351</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6ZTA2YmMyNDc4OWM2NGI5NzlmMmMzNjE1MjMwMmM3NjYvdGFibGVyYW5nZTplMDZiYzI0Nzg5YzY0Yjk3OWYyYzM2MTUyMzAyYzc2Nl8wLTQtMS0xLTA_95860254-088e-418e-93f1-c6efac036607">35-0470950</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDI3_627f1af7-f01e-4eb8-a427-1199d83568bf">Lilly Corporate Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMy_84ac102c-11c8-4bff-bd83-72ea06fb2c04">Indianapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDI4_40977120-3435-453c-a72d-5f35f992bf0b">IN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDI5_9973c862-aba0-4557-a858-95e4bda91984">46285</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDMz_6de7f4d4-9712-46bc-8f03-c3163325e6be">317</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDM0_a3d10999-b396-4f37-92d3-f37e21b59a8d">276-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6MzM4ZTQxMjYzNWU1NDRiZmJlNjUwM2JlNjdhNWNlNWIvdGFibGVyYW5nZTozMzhlNDEyNjM1ZTU0NGJmYmU2NTAzYmU2N2E1Y2U1Yl8wLTAtMS0xLTA_08146b22-26ea-4c66-8f39-e2b4a2175d76">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6YzJmNjY4NzFmNGQyNDkzODljZTI5Mzk3MWM5MTU3NTYvdGFibGVyYW5nZTpjMmY2Njg3MWY0ZDI0OTM4OWNlMjkzOTcxYzkxNTc1Nl8wLTAtMS0xLTA_684de583-3aa3-44fb-b9de-f6950afdfbc5">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6NmVlZWU3YjhlMGQzNDZkNDgxNmI0NTViYzQwMjI0MmEvdGFibGVyYW5nZTo2ZWVlZTdiOGUwZDM0NmQ0ODE2YjQ1NWJjNDAyMjQyYV8wLTAtMS0xLTA_61b8aaee-66a6-41f5-8393-fe0e7885ae28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6YmE2ZWNlYTQxODY3NDY1MGEwYjQwZGIwYzBlYjkyOGYvdGFibGVyYW5nZTpiYTZlY2VhNDE4Njc0NjUwYTBiNDBkYjBjMGViOTI4Zl8wLTAtMS0xLTA_679ee1af-730a-45c3-8a81-b3934fabcf4a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18xLTAtMS0xLTA_2c729e62-4d63-4d2d-a180-59f8937f138c">Common Stock (no par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18xLTItMS0xLTA_81bff4df-95ad-4329-8000-9cabfc945e18">LLY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i29e6e833e4f7465c92af3a8e1e9aedd6_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18xLTQtMS0xLTA_6b142dbe-b861-405e-b6db-ef0b93391a88">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18yLTAtMS0xLTA_cbc91c4f-f7b3-43a5-aef7-9f3315f8203a">1.000% Notes due 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18yLTItMS0xLTA_3aca0f91-8346-4404-aa91-4ffe97f79206">LLY22</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i77b52ac10f404dd590f328633e9361e2_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18yLTQtMS0xLTA_23d56059-e9ec-4a52-933f-ab62792609e8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18zLTAtMS0xLTA_6c987025-2d54-4156-9281-fade28a53593">7 1/8% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18zLTItMS0xLTA_29bd2f92-14c3-4e62-8d7f-3d6ff9d3e8b0">LLY25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i59255a0198d6401c93ecfda3111cc12d_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY18zLTQtMS0xLTA_f4a52e4b-cdfd-4f50-b954-c673bc1057bc">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY180LTAtMS0xLTA_ca8db353-5949-4e69-bc06-f4b3bbd43d2c">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY180LTItMS0xLTA_b66b2a96-695e-407f-a750-5b1ed75a4f1e">LLY26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia6c8598ff0ec4421a57337abe15abcbf_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY180LTQtMS0xLTA_87d52880-72ec-4dfb-ab5e-edc1dd13f057">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY181LTAtMS0xLTA_faababd7-edb5-4340-85b5-86d08a8ab5e4">2.125% Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY181LTItMS0xLTA_78f2a262-24f9-43db-9920-be665d9187f9">LLY30</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifcf0bfdc7f6c484ba164a23b5f63ca7b_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY181LTQtMS0xLTA_c6b2db53-0852-40d9-b325-fccd65e7b703">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY182LTAtMS0xLTA_90224226-bd81-4d1c-9327-c0db3497f98b">0.625% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY182LTItMS0xLTA_3348979d-5931-42f2-96c8-8ecfdbe78820">LLY31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i52a2148d0f6340928035f1675ab1f2e0_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY182LTQtMS0xLTA_f03dba10-85eb-4811-bf48-5c1a8f87645e">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY183LTAtMS0xLTA_ca024941-b75d-4007-a377-25578afb7593">6.77% Notes due 2036</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY183LTItMS0xLTA_a4c3836f-c5f8-4944-abe5-02da82111cc3">LLY36</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9ddda85799ef4e8194ca3a006cb419af_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY183LTQtMS0xLTA_e2581745-bbf1-4504-9f9d-a600aac180d7">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY184LTAtMS0xLTA_2e1ee105-cebe-424b-b18d-a752014178b2">1.700% Notes due 2049</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY184LTItMS0xLTA_0b4c487b-e739-4a82-901a-e9d099d06335">LLY49A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i15240bbc9d104558adb8ca0aa1bb2285_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGFibGU6OTE5MTc4NWZlNzEzNGEwY2IyMjU5ODQ4MDczYjMxMWMvdGFibGVyYW5nZTo5MTkxNzg1ZmU3MTM0YTBjYjIyNTk4NDgwNzNiMzExY184LTQtMS0xLTA_4c0ea87c-d419-4243-974f-274b393a67b6">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhMTNhMDE1OTliMzRkMTA4YTVlNjY3MzE1MmY4ZDMyL3NlYzozYTEzYTAxNTk5YjM0ZDEwOGE1ZTY2NzMxNTJmOGQzMl8xL2ZyYWc6YTk4OGVmMzQxZDMzNGRmYmFmNDI3MWQ3YzQ3ZDc3YTgvdGV4dHJlZ2lvbjphOTg4ZWYzNDFkMzM0ZGZiYWY0MjcxZDdjNDdkNzdhOF8xNDM1_0c9554c5-608a-4565-97d2-5af0df0dc26d">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140338714086264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Dec. 15, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 15,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">IN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-06351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">35-0470950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Lilly Corporate Center<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Indianapolis<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">46285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">276-2000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ELI LILLY AND COMPANY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000059478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Stock (no par value)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock (no par value)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lly_A1.000NotesDueJune22022Member', window );">1.000% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lly_A718NotesDueJune12025Member', window );">7 1/8% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">7 1/8% Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lly_A1.625NotesDueJune22026Member', window );">1.625% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lly_A2.125NotesDueJune32030Member', window );">2.125% Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125% Notes due 2030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lly_A625Notesdue2031Member', window );">0.625% Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Notes due 2031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lly_A6.77NotesDueJanuary12036Member', window );">6.77% Notes due 2036</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">6.77% Notes due 2036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lly_A1.700Notesdue2049Member', window );">1.700% Notes due 2049</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.700% Notes due 2049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LLY49A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lly_A1.000NotesDueJune22022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lly_A1.000NotesDueJune22022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lly_A718NotesDueJune12025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lly_A718NotesDueJune12025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lly_A1.625NotesDueJune22026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lly_A1.625NotesDueJune22026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lly_A2.125NotesDueJune32030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lly_A2.125NotesDueJune32030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lly_A625Notesdue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lly_A625Notesdue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lly_A6.77NotesDueJanuary12036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lly_A6.77NotesDueJanuary12036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lly_A1.700Notesdue2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lly_A1.700Notesdue2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M]RFJ5%:Q"TN&[59P@<!O8T8L^GT<W@,90TY&,YECX'"(T';K%)8\V,ST[77
MQ_']30FM>0Z)R;)%OL9&4>L*%YJPM."8)8M_'T?T&*9+++3(I^0+M+<2+*WU
M@ZLX_5C8^SBI1XJ?QI >#O-K=>'F>0)+EJ^3R9;ZX7I.9Q;[/D[IGYSUBV(!
MSIP&<5FG00M^?R?R7V=<34T]?P,%/3/--F?Y4ZTU7-!IS8+>WXGT-WPJ"JT8
M)&_(LGHV.(0&?3+H#P9WI#O\2'I?OXRZPSML+6II3W>BO;FX*< &7$WX(_G,
M:_/FD/+,O^@\;'<P9Q;V%$=S%[HM*3ON4\JFM7YP 5<=Z<:*W<%VZ']8Z(RU
MC+^3M[DD<Z;( TL7_!VF;Y%-@Z/=$E"+88K3\U9H6$O*"?'IV_MW9,SC!8"Y
MOM*XTO_,AZ4SQ;EZJUABIO+X*;N7M6!V",!,P8Q8+%,<H\\Y(M>/\8SE4[YU
M CN$AG?C:\R1Q3'%N>F?P23[E0REY@5)%MS<E5),V7*4=H[7A!:)%"?9/DV(
M*^V;B< R,<!!YFX_AP"T'V[%0C# &;9[ SJ$' T86!8&. O;Q&]V7J0=6T$'
M&\\LCD?!P%(P.!@%'4I[9\+R+W@M_QP"I@%1*Y: P:$(Z!!R-: E8. B8(M&
M+]+>PI0M 8/C$3"P! P.1D"'TKZ9""T!P]<2T"%@&A"U8@D8'HJ #B%' X:6
M@"%.0'KFOTQ[@-THAY: X?$(&&X\ECT8 1U*>V?"$C!\+0$= M" N!5+P/!0
M!'0(N1K0$C#$">C]/.\#[!%O: D8'H^ H25@># ".I3VS41D"1B]EH . =.
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( &D[CU$'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ :3N/469:6%;N    *P(  !$
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M;',O+G)E;'-02P$"% ,4    " !I.X]1&445]3<!   G @  #P
M    @ 'V$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ :3N/420>FZ*M
M    ^ $  !H              ( !6A(  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ :3N/4660>9(9 0  SP,  !,
M ( !/Q,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  B10
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>9</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lly-20201215.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lilly.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lly-20201215.htm">lly-20201215.htm</File>
    <File>lly-20201215.xsd</File>
    <File>lly-20201215_cal.xml</File>
    <File>lly-20201215_def.xml</File>
    <File>lly-20201215_lab.xml</File>
    <File>lly-20201215_pre.xml</File>
    <File>lly-2021financialguida.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lly-20201215.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 9,
   "dts": {
    "calculationLink": {
     "local": [
      "lly-20201215_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lly-20201215_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "lly-20201215.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lly-20201215_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lly-20201215_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lly-20201215.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 35,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 7,
   "memberStandard": 1,
   "nsprefix": "lly",
   "nsuri": "http://www.lilly.com/20201215",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lly-20201215.htm",
      "contextRef": "ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.lilly.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lly-20201215.htm",
      "contextRef": "ic23f9ca8c91e403ab8e239d35fe2f61e_D20201215-20201215",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 8,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "lly_A1.000NotesDueJune22022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.000% Notes Due June 2, 2022 [Member]",
        "label": "1.000% Notes Due June 2, 2022 [Member]",
        "terseLabel": "1.000% Notes due 2022"
       }
      }
     },
     "localname": "A1.000NotesDueJune22022Member",
     "nsuri": "http://www.lilly.com/20201215",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "lly_A1.625NotesDueJune22026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due June 2, 2026 [Member]",
        "label": "1.625% Notes Due June 2, 2026 [Member]",
        "terseLabel": "1.625% Notes due 2026"
       }
      }
     },
     "localname": "A1.625NotesDueJune22026Member",
     "nsuri": "http://www.lilly.com/20201215",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "lly_A1.700Notesdue2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.700% Notes due 2049 [Member]",
        "label": "1.700% Notes due 2049 [Member]",
        "terseLabel": "1.700% Notes due 2049"
       }
      }
     },
     "localname": "A1.700Notesdue2049Member",
     "nsuri": "http://www.lilly.com/20201215",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "lly_A2.125NotesDueJune32030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.125% Notes Due June 3, 2030 [Member]",
        "label": "2.125% Notes Due June 3, 2030 [Member]",
        "terseLabel": "2.125% Notes due 2030"
       }
      }
     },
     "localname": "A2.125NotesDueJune32030Member",
     "nsuri": "http://www.lilly.com/20201215",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "lly_A6.77NotesDueJanuary12036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.77%\u00a0Notes Due January\u00a01, 2036 [Member]",
        "label": "6.77%\u00a0Notes Due January\u00a01, 2036 [Member]",
        "terseLabel": "6.77% Notes due 2036"
       }
      }
     },
     "localname": "A6.77NotesDueJanuary12036Member",
     "nsuri": "http://www.lilly.com/20201215",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "lly_A625Notesdue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": ".625% Notes due 2031 [Member]",
        "label": ".625% Notes due 2031 [Member]",
        "terseLabel": "0.625% Notes due 2031"
       }
      }
     },
     "localname": "A625Notesdue2031Member",
     "nsuri": "http://www.lilly.com/20201215",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "lly_A718NotesDueJune12025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7 1/8% Notes Due June\u00a01, 2025 [Member]",
        "label": "7 1/8% Notes Due June\u00a01, 2025 [Member]",
        "terseLabel": "7 1/8% Notes due 2025"
       }
      }
     },
     "localname": "A718NotesDueJune12025Member",
     "nsuri": "http://www.lilly.com/20201215",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "terseLabel": "Common Stock (no par value)"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.lilly.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000059478-20-000190-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000059478-20-000190-xbrl.zip
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M3^8@CG4*I2-,$;77RD(N%7#&BL>)YWGK(U/1VGE-UU<$Q;&YVF:WP^>3FQ[
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M8(Z\$.BXM#&6,B N5JOIFML!3@3EV/<#3Q',A7"E\EUPDE(2WZ?4%2LZ\L0
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M:<D/"UY@6O-F^-+\.([Z)0D\#_CF-7R) 9Q3 \"P-A*#IWQM;@N':3_*"M8
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M9HGCW,*)W\E)5F6N-ZSKDLV+G7W"A-_KB\+7_42-X4<G[\6;_P]02P,$%
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M5O!:_]$&S Y& <(+;,BKI]ZN?@%02P,$%     @ :3N/4:"P$+FO"0  ,$@
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MOU-](O #E.SJ#!1>Z0/PIY.Z";'9G^(<4GZ(35&'MU5X UG1G&E'"78<":$
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M#F2EDTC%WEE#++4YBN_[$>R:[$^G=U-T/4;T?M8Y:*(=<,B(K4Z<HD"P['%
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M<C1$'\*Q>Q$PCNHM<9"A9_9V$9L3F)#^V=3GW2F@/;/5Y5PHJH)('DFB(;6
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M^6[78V/J=KJ>M.E1X$B>$?(8]?/U/<]LMV&\?Q0<2ZO94 O B?V!!%> &6)
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MGJTW??"R[%&W$R_'UAMUN@S;T,Y?PK]ERSS7Z^OT]O9^O3O!8K,@@B%N(W)
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M8EP?7SZ[^:#[T_V U,MG_P-02P,$%     @ :3N/49@Z$?8B(0  & H! !H
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M8 !B^!!?S29T 5#<#F8Z!F<I,68&/XU4DDBP'F""\-L@];6,?&!.,4I]#K'
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M?P5T^+!H=)0+=5^2M?*)!+<A&[$J\L!0012/HR!?%B%.B;$]R0? P\"LX-O
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MWR^R-F'81&I@!,TFDXGCXT/'54%64C0[&G5I' @J1-#LF-H-MAN,.P$VFTQ
MF0&_24PXOOC\PC:JQ!7:[QC';@K$>)B'#/;8AQ>N)*<E65"VGQ)[5]X[&ZCT
MKB6&GP%+"7LG)NRC"GAX[QS/6T";S?7</JHN?&D8D-CBW*00;U%"#2R8GVU+
MX=A8<%^/7521ON  N*G#2T.)I6KP._H!$ZG'6#SF@O:,L2,KPYHV$*- >-*E
M.B_Z*N"7,(P<4H,-D Y3X"=4A*J7NK<8SE>Q[SGL"\H ]6A%C'DL4*BGQZ@*
M&+H**4S%1XJZ\L+0(97)26W3T@D"!&X,ZZO_-Z7:X 6 A- @=[#.4 C/EOL8
M.9V@,<$Z/*9CTU[&?"$3:J&,(@]"K-(8P;UTV)E+.1NDO !UHF8)*X+(5U,!
M,^)[.$Z&*)IL0 A$G-2I!S25<!1 XJPJ 42,%8&(XP<U+.*+L<TSSD;LE&AN
M.[; F( +/J(:/U2/,!W6%YJUC5!W#KA+@""^D)"2T&$48S0&C13BOR+#E-AB
M!&PG\%,"6NUU_>W;/_8)[(\]@;W96%-;ML9M,+?[5#XAC1=&C8:0&ZGDBMH:
M%\R:&V$WC6-3@865O=26F_JHS_<41^X?IJ 'D+E1&(<@)Q)+S4QGYPF/O3KS
ME;I$R0 1T<(XA*BOK"L8"$Z=X^';3UCH@KV$>V>96_&IZ*=\YI(T-?OM-D&3
MO]V\J'C[XMIV="\^ZQ@? K2 ES!<:ZMQFG4,HG\V3VO9[R#=?\'X\S\30KSY
M7PU>YG\="%^*JX61-?"!6'BY:(1DGY@"8PGTYS$B'FEG"!$+0Q?/J%F);?[D
M<)KC>Q'=J!MU6FINC:V[/#D$5XKAXF-3MVR;>%V!20$'D0VYBQXA(2T6-&\"
M088<0L !O 'JZ-*P!?J0,?(2(1[(&H%#'W"7VE.962L+$&=JV+'4.DU0YR8S
M18H<:Y\,2?%SET=28Q6V[RO7%%!3RA"X@&*AB=9\15 V0;8D=&K!"0P5N*L@
M8:ADK5F*9$2E_47Q.WF,6/<NK=8/!7K#'$P@%E+30JWJ3Q%S:6S::(]2 $G%
MMF_]%?>3FID"QK W(UA+0H5<1:$Y$"1)R>,>IG[QS>RE"CGQ01CQ@2_0=<;&
M6D7?L 0?@@\OPH3D+,)-)VMU:DS%"T/G^/($6L[,C&6HIXF'_ J\J0'Z*O -
MB!CV?2_<_\Q4S#0"R,<MLR$@Q%2P49D;EJ?1NL<9^R%O(&P@IE9+%*+B5>+7
M]&GGP)5C[-0^!$I-<CI"A- _Q1+-2_ [TDBC/T15RUE# _.=-_<!KD!H265X
M)>Y,+-@(6:8S<X[)(JGYU6>\948V]T)$,BZW7P69$$9B(RS$C\%O@K]HJ_!0
M\UJ)RQ3?PAPST%>]P0>2_#%@.SNT4?$AC.X*V]/!E@G:RLT*L(KQ+1L@?5S+
M=4,V0B\KI%X'1CJB6%ZA6QKQ*;80++!'/>]B=+J0QC4@B P&:9P8)PI@LH7@
M)@1%H&=TC%UHB1U(&JC_$P(+$5Y <E! 9&->.3+V;&& ;!GP$W:2*B@,7&+X
M9X%+$CX4FF11#%%+N@@&*D=4VTFB0#3P(W+6;Z<:7:A@3&7V!"0CBE Q@&(G
M<:"F$K,J!_6Z=$&^4"$"*.!]QL#HE6LT)I)>4[:A?\';EO/M*ZC639\/GT\8
M!<LTC,51KG<]KGD=6.$2?(IR2Q S&K"<13BB7_E7"'$$@7HMEQ\8VK@4<^A(
M0YZ"*X[UGM0GP_550HX'! 0D^\ ^-'(M4X: &_"\241B")SP;H98Z-)J<3?!
M:%!@3P2<X1Y(L4LU3Q^)PA%8JS-%(H "#87&N,*("I !Q:K0K,H",):Q9UJ$
M9"0UCE)9H],^6$*:%(%9P#_6_R+R<:(2]LM5][.2B'U 3-6P0, A?AS)Q'P%
M@LY=NR'W"I0?MO1DK4:S9T<W],QV<19  4SX%MFH%P!L3:7)-H"#V<#[#"U-
M7>P_8KTQ>LD,1[VE"5H9![FRP:'B-&-F^ J\I456!#T ,:FV;D[H<73ID."I
M/^+6BB NBCM3SHHO/N5?_*+@/[FB+GF/U 0E@_D<HUH3=!Y\NCA_8<$O6U@*
M)*O<%^"\,,E421FUB+:15?K4 70E56V*P5,J L=]5:4S[I5X,P=I6-,TAMQ'
MVEB-192"]X4^OW6FK#"6V1D,P#B$ &0TM9P-3T%F(&IWK1Y1^:'#D$O?7NZQ
MH/S)G&6"G7=O@.5X(I!NK=A>-)L;,$JDL,:?+C;2*M-05G,C8"@Y=92<J<$=
M8G(L(VN:4ITH6!T%WC%U""CI+HJWS41@*F*%=YJ 3G!1\#U#.>HOA)OLAIG+
MXICUMT7G!'<(L;\M H9.#[CCGG3UW.(3" / /:9;<-#>H*!DU^'D&Z(#,546
M":&XUJS98A#:Z7%2( <]\(SH,&SF":'22Y,DUT])'F-5A5@N74!%[9KXC.-N
M7':[ EI9MH)JK6>U,6WS6\_-8:^!(S*T 7K+K,1Q]]&$AA9P<C -/"Y/#1^6
MPQ':DIF/1LBT+8]I:BPR<6PB1"78*&:@E5ZCXFLVZO\R$I$.$F!JE$Q\D."3
M_Z,GQ_#&D.[ORLTSR+K#_E IR!'!CLP0^>!SX(Y/*F;8]"9 C:8'YN"XWXU;
MC4DF*GBKF+4/>63NH.81D::H"'\%/1,;E0;:?Z&O$P:&&+RA1>0R2,C]!X<G
ML[/H*]$>OC_-8W]\!<\!3$0);RP'W[ ]G>DPK( BGU>+>#GXV]D]O7%KYH>[
M/UBZC99UVS='=O7^NC9R5NIN?>O.^NI_/@B95MN-6G<WS2.GN\*\RWK[M>GK
MC35!7 U%[  &2%T9IP$?V)WL%ULDV=I[>SY)F@&.P,2*KTBT^BCT@QV@W/K[
M(&^ =&S3M#L08%!'OASZZJL$1_ 7)<88@5"YQTCX\'*P32JNO4WSDY2_ <<M
M) A2Y)9UIJW"6V\+VQ5(=L,-&+>0;)TM;%=##SN N;%/&=\!@IE3LK7>/? D
MU:2\%I?RZXXX)>N_4N-)TLQ+?3!MJ9:>V &MN-[^YP^J$S=NQC*]B$>IO@0A
M8S+\RYSZ+*7</KWCT;==7DV.UW[MRY-T ?E !-R5KG^#1[%K(G,X4-X4_C/6
M@?_S_P-02P$"% ,4    " !I.X]1!-//"V\?  #$^@  $
M@ $     ;&QY+3(P,C Q,C$U+FAT;5!+ 0(4 Q0    ( &D[CU$QY5?BJP,
M *L0   0              "  9T?  !L;'DM,C R,#$R,34N>'-D4$L! A0#
M%     @ :3N/4;LSI]"# 0  RP(  !0              ( !=B,  &QL>2TR
M,#(P,3(Q-5]C86PN>&UL4$L! A0#%     @ :3N/4:"P$+FO"0  ,$@  !0
M             ( !*R4  &QL>2TR,#(P,3(Q-5]D968N>&UL4$L! A0#%
M  @ :3N/4?[# LW&#P  #I<  !0              ( !#"\  &QL>2TR,#(P
M,3(Q-5]L86(N>&UL4$L! A0#%     @ :3N/4704Q-A'"0  #DP  !0
M         ( !!#\  &QL>2TR,#(P,3(Q-5]P<F4N>&UL4$L! A0#%     @
M:3N/49@Z$?8B(0  & H! !H              ( !?4@  &QL>2TR,#(Q9FEN
E86YC:6%L9W5I9&$N:'1M4$L%!@     '  < S $  -=I      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
